title: Cerebral ergotism under treatment with ergotamine and ritonavir.
authors.affiliation: Departments of Neurology, University Hospital Innsbruck, Austria. michael.spiegel@uibk.ac.at
authors.forename: M
authors.initials: M
authors.lastname: Spiegel
authors.forename: C
authors.initials: C
authors.lastname: Schmidauer
authors.forename: A
authors.initials: A
authors.lastname: Kampfl
authors.forename: M
authors.initials: M
authors.lastname: Sarcletti
authors.forename: W
authors.initials: W
authors.lastname: Poewe
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000009:adverse effects*; D004881:Ergotism / Q000175:diagnosis; D005260:Female; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D019438:Ritonavir / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000009:adverse effects*; D020301:Vasospasm, Intracranial / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D017320:HIV Protease Inhibitors; D014662:Vasoconstrictor Agents; D019438:Ritonavir; D004878:Ergotamine